Hints and tips:
Showing results for Sanofi-Aventis, U.S., Inc.
...(FT) UK care crisis The general election campaign was dominated by a Conservative U-turn over social care plans, dubbed a “dementia tax” by opponents....
...While not seen in Germany before, Braas’s tactic has some similarities to that deployed by French drugmaker Aventis in 2004, in an attempt to avoid being acquired by Sanofi in a $60bn deal....
...Sanofi and Aventis merged to take on US pharma, but have not caught Pfizer. Nor have Glaxo and SmithKline Beecham....
...not a household name, its fight against the FDA was backed by a consortium of 11 of the biggest names in the pharmaceuticals industry — including Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis and Sanofi...
...(Reuters) “Exelon, the largest U.S. nuclear operator, has agreed to buy Pepco Holdings Inc. for more than $5.4 billion in cash, according to people familiar with the transaction.”...
...Expansion by larger drug companies was the norm at the start of this century, from the merger that created GlaxoSmithKline in 2000 and the $67bn purchase of Aventis by Sanofi in 2004, to Pfizer’s $68bn paid...
...Amgen, Sanofi-Aventis and Pfizer have all made acquisitions in this area in Brazil....
...Mr Soriot, 53, a Frenchman who trained as a veterinary surgeon before obtaining an MBA, worked for much of his career in Asia for Roussel Uclaf, Hoechst and Aventis, which became part of Sanofi in 2004....
...It was the largest bond sale in the US since March 2011, when Sanofi-Aventis sold $7bn, Dealogic said....
...That is good news for the backlog of other companies awaiting similar appeals, including brewer SABMiller, US wireless operator AT&T, and French drugmaker Sanofi-Aventis....
...Shire had little incentive to fund the extra tests as production at Genzyme, now owned by Sanofi-Aventis, would return to normal later this year, analysts said....
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
...Aventis Pharma seals deal to buy Universal Medicare Aventis Pharma, a part of French drug maker Sanofi has entered into a definitive agreement to acquire Universal Medicare’s marketing and distribution business...
...Sanofi-Aventis investors, meanwhile, will pore over the impact of its recently lost patents. Stepping back, investors should watch for the impact of recent government cuts to drug prices....
...For example, Sanofi-Aventis, the French multinational pharmaceutical company, is using Microsoft’s SharePoint to revamp its R&D process....
...The action follows the arrests last year in Belgrade of senior officials at the Serbian Institute for Oncology and Radiology, as well as the heads of the Belgrade offices of AstraZeneca, Roche, Actavis, Sanofi-Aventis...
...Sanofi-Aventis plans to cut costs and expand its animal health business through acquisitions as it fully integrates Merial after the collapse of its longstanding joint venture with Merck of the US....
...Merck and Sanofi-Aventis have abandoned plans to create the world’s largest animal health company, scrapping a joint venture with combined sales of $5.5bn that was announced a year ago, in a move they blamed...
...Sanofi-Aventis brought an end to its protracted pursuit of Genzyme with an agreed $20.1bn cash takeover of the US biotech company, coupled with additional conditional payments over the next decade, reports...
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
...Sanofi-Aventis cautioned that 2011 earnings were likely to be down by as much as 10 per cent from last year’s €7.06 ($9.68) a share as a result of increased pricing pressure and threats from generic competition...
...He said that there could also be legal disputes over Sanofi-Aventis’ implementation of its pledge for “diligent efforts” to develop Lemtrada....
...Merck maintains a development and marketing partnership for vaccines in Europe with Sanofi-Aventis, and until the recent collapse of talks it was planning a renewal of Merial, its long-standing partnership...
...Such thinking has guided it through a flurry of more than a dozen deals and underpins its $5.7bn bid for Cephalon, which would be the largest hostile takeover in healthcare since Sanofi-Aventis bagged Genzyme...
International Edition